EGEN-COVTM (casirivimab and

imdevimab)

EUA

PEP, higher-risk groups.

https://www.fda.gov/media/145610/download

https://www.fda.gov/media/145611/download

>>14438352

>>14438352

https://pubmed.ncbi.nlm.nih.gov/34237773/